Summarized by Masters of Longevity from Longevity Technology.
1726 reduced body weight and improved liver measures versus retatrutide.

Key Takeaways
- MetaVia presented preclinical head-to-head data at ObesityWeek 2026.
- DA-1726 reduced body weight in the reported rodent models.
- DA-1726 showed liver-related benefits versus retatrutide in rodents.



